Cited by 1,082Antibiotic Resistance in BacteriaDrug Transport and Resistance MechanismsBacterial Genetics and Biotechnology

The DOI matches its Crossref record; 733 of the 733 references it cites were found in a registry or an index.

Efflux-mediated antimicrobial resistance

Poole, Keith·2005·Journal of Antimicrobial Chemotherapy

DOI 10.1093/jac/dki171

Open this paper in CoChat — free account

Abstract

Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease. And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of reduced biocide susceptibility are common and the history of antibiotic resistance should not be ignored in the development and use of biocidal agents. Efflux mechanisms of resistance, both drug specific and multidrug, are important determinants of intrinsic and/or acquired resistance to these antimicrobials, with some accommodating both antibiotics and biocides. This latter raises the spectre (as yet generally unrealized) of biocide selection of multiple antibiotic-resistant organisms. Multidrug efflux mechanisms are broadly conserved in bacteria, are almost invariably chromosome-encoded and their expression in many instances results from mutations in regulatory genes. In contrast, drug-specific efflux mechanisms are generally encoded by plasmids and/or other mobile genetic elements (transposons, integrons) that carry additional resistance genes, and so their ready acquisition is compounded by their association with multidrug resistance. While there is some support for the latter efflux systems arising from efflux determinants of self-protection in antibiotic-producing Streptomyces spp. and, thus, intended as drug exporters, increasingly, chromosomal multidrug efflux determinants, at least in Gram-negative bacteria, appear not to be intended as drug exporters but as exporters with, perhaps, a variety of other roles in bacterial cells. Still, given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents, for example, less impacted by efflux and in targeting efflux directly with efflux inhibitors.

Integrity signals

Registry

Crossref · 10.1093/jac/dki171

Cites

733 of 733 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli
Ma, C., & Chang, G. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400137101 · Cited by 102
Retracted
Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G. E., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,795
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. M. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,152
Understanding biofilm resistance to antibacterial agents
Davies, D. G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,786
Survival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,797
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Efflux-mediated heavy metal resistance in prokaryotes
Nies, D. H. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00048-2 · Cited by 1,567
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523

Show all 733 references

Research works printed but not linked: 2

Bartlett JG. 2004 Pocket Book of Infectious Disease Therapy, 12 edn. Baltimore: Lippincott Williams & Wilkins, 2004.
Kumar A, Worobec EA. Cloning sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother2005; 49: 1495–1501. · DOI

Sorted by citations

Items 201–300 of 1,001

Antimicrobial resistance determinants of Escherichia coli isolates recovered from some rivers in Osun State, South-Western Nigeria: Implications for public health
Titilawo, Y., Obi, L., & Okoh, A. I. (2015) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2015.03.095 · Cited by 96
Efflux pump inhibitors: new updates
AlMatar, M., Albarri, O., Makky, E. A., & Köksal, F. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00160-9 · Cited by 92
Kinetic Parameters of Efflux of Penicillins by the Multidrug Efflux Transporter AcrAB-TolC of Escherichia coli
Lim, S. P., & Nikaido, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01714-09 · Cited by 92
Characterization of the Vibrio cholerae vexAB and vexCD efflux systems
Bina, J. E., Provenzano, D., Wang, C., Bina, X. R., & Mekalanos, J. J. (2006) · Archives of Microbiology · doi:10.1007/s00203-006-0133-5 · Cited by 92
Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF)
Bohnert, J. A., Schuster, S., Fähnrich, E., Trittler, R., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl426 · Cited by 91
Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Takahashi, Y., & Igarashi, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.117 · Cited by 90
Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time
Zwama, M., & Nishino, K. (2021) · Antibiotics · doi:10.3390/antibiotics10070774 · Cited by 90
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity
Karine de Sousa, A., Rocha, J. E., Gonçalves de Souza, T., Sampaio de Freitas, T., Ribeiro-Filho, J., & Melo Coutinho, H. D. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.07.040 · Cited by 88
Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions
Schick, A., & Kassen, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721270115 · Cited by 88
Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics
Yang, X., Ye, W., Qi, Y., Yin, Y., & Xia, Z. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.696514 · Cited by 93
The Multidrug Efflux Pump MdtEF Protects against Nitrosative Damage during the Anaerobic Respiration in Escherichia coli
Zhang, Y., Xiao, M., Horiyama, T., Zhang, Y., Li, X., Nishino, K., & Yan, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243261 · Cited by 87
In Vitro Study of the Effect of Cationic Biocides on Bacterial Population Dynamics and Susceptibility
Moore, L. E., Ledder, R. G., Gilbert, P., & McBain, A. J. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00573-08 · Cited by 89
Review on PLGA Polymer Based Nanoparticles with Antimicrobial Properties and Their Application in Various Medical Conditions or Infections
Shakya, A. K., Al-Sulaibi, M., Naik, R. R., Nsairat, H., Suboh, S., & Abulaila, A. (2023) · Polymers · doi:10.3390/polym15173597 · Cited by 93
Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens
Fraimow, H. S., & Tsigrelis, C. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.002 · Cited by 87
Effect of the F610A Mutation on Substrate Extrusion in the AcrB Transporter: Explanation and Rationale by Molecular Dynamics Simulations
Vargiu, A. V., Collu, F., Schulz, R., Pos, K. M., Zacharias, M., Kleinekathöfer, U., & Ruggerone, P. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202666x · Cited by 87
Targeted polymer-based antibiotic delivery system: A promising option for treating bacterial infections via macromolecular approaches
Wang, T., Rong, F., Tang, Y., Li, M., Feng, T., Zhou, Q., Li, P., & Huang, W. (2021) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2021.101389 · Cited by 88
Role of EfrAB efflux pump in biocide tolerance and antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from traditional fermented foods and the effect of EDTA as EfrAB inhibitor
Lerma, L. L., Benomar, N., Valenzuela, A. S., Muñoz, M. D. C. C., Gálvez, A., & Abriouel, H. (2014) · Food Microbiology · doi:10.1016/j.fm.2014.06.009 · Cited by 87
Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil
Minarini, L. A. D. R., & Darini, A. L. D. C. (2012) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822012000400010 · Cited by 85
Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, H. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688949 · Cited by 84
Environmental impact of medical prescriptions: assessing the risks and hazards of persistence, bioaccumulation and toxicity of pharmaceuticals
Deblonde, T., & Hartemann, P. (2013) · Public Health · doi:10.1016/j.puhe.2013.01.026 · Cited by 83
Antimicrobial Resistance in Pasteurellaceae of Veterinary Origin
Michael, G. B., Bossé, J. T., & Schwarz, Š. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0022-2017 · Cited by 82
In Vitro antibacterial and antibiotic-potentiation activities of four edible plants against multidrug-resistant gram-negative species
Noumedem, J. A. K., Mihăşan, M., Kuiaté, J. R., Ștefan, M., Cojocaru, D., Dzoyem, J. P., & Kuete, V. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-190 · Cited by 80
Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels
Alcaide, E., Blasco, M. D., & Esteve, C. (2009) · Research in Microbiology · doi:10.1016/j.resmic.2009.10.006 · Cited by 81
The safety and efficacy of dressings with silver – addressing clinical concerns
CUTTING, K. F., White, R. J., & Edmonds, M. E. (2007) · International Wound Journal · doi:10.1111/j.1742-481x.2007.00338.x · Cited by 81
Liposomal antibiotics for the treatment of infectious diseases
Alhariri, M., Azghani, A. O., & Omri, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.822860 · Cited by 85
Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
Subedi, D., Vijay, A. K., Kohli, G. S., Rice, S. A., & Willcox, M. D. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204936 · Cited by 80
On the evolutionary ecology of multidrug resistance in bacteria
Lehtinen, S., Blanquart, F., Lipsitch, M., & Fraser, C. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007763 · Cited by 80
Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
Foulkes, D. M., McLean, K., Haneef, A. S., Fernig, D. G., Winstanley, C., Berry, N. G., & Kaye, S. B. (2019) · Microorganisms · doi:10.3390/microorganisms7120707 · Cited by 86
Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps
Fernández-Cuenca, F., Tomás, M., Caballero-Moyano, F. J., Bou, G., Martı́nez-Martı́nez, L., Vilà, J., Pachón, J., Cisneros, J. M., Rodríguez‐Baño, J., Pascual, Á., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv262 · Cited by 80
Biocidal Resistance in Clinically Relevant Microbial Species: A Major Public Health Risk
Meade, E., Slattery, M. A., & Garvey, M. (2021) · Pathogens · doi:10.3390/pathogens10050598 · Cited by 81
The expression of antibiotic resistance genes in antibiotic‐producing bacteria
Mak, S., Xu, Y., & Nodwell, J. R. (2014) · Molecular Microbiology · doi:10.1111/mmi.12689 · Cited by 78
Broad-Spectrum Antibiotic Activity of the Arylomycin Natural Products Is Masked by Natural Target Mutations
Smith, P. A., Roberts, T. C., & Romesberg, F. E. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.09.009 · Cited by 77
Role of Quaternary Ammonium Compounds on Antimicrobial Resistance in the Environment
Tezel, U., & Pavlostathis, S. G. (2011) · Antimicrobial Resistance in the Environment · doi:10.1002/9781118156247.ch20 · Cited by 90
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 82
Virulence‐targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms
Ruer, S., Pinotsis, N., Steadman, D., Waksman, G., & Remaut, H. K. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12517 · Cited by 74
Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
Ndagi, U., Falaki, A. A., Abdullahi, M., Lawal, M. M., & Soliman, M. E. S. (2020) · RSC Advances · doi:10.1039/d0ra01484b · Cited by 80
Dominant chloramphenicol-resistant bacteria and resistance genes in coastal marine waters of Jiaozhou Bay, China
Dang, H., Ren, J., Song, L., Sun, S., & An, L. (2007) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-007-9458-8 · Cited by 76
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment
Gomez, J. E., Kaufmann-Malaga, B., Wivagg, C. N., Kim, P. B., Silvis, M. R., Renedo, N., Ioerger, T. R., Ahmad, R., Livny, J., Fishbein, S. R. S., et al. (2017) · eLife · doi:10.7554/elife.20420 · Cited by 71
SOS response and its regulation on the fluoroquinolone resistance.
Qin, T., Kang, H., Ma, P., Li, P.-P., Huang, L., & Gu, B. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.12.09 · Cited by 79
Biocides and health-care agents are more than just antibiotics: Inducing cross to co-resistance in microbes
Paul, D., Chakraborty, R., & Mandal, S. M. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.02.083 · Cited by 76
Molecular Rationale behind the Differential Substrate Specificity of Bacterial RND Multi-Drug Transporters
Ramaswamy, V. K., Vargiu, A. V., Malloci, G., Dreier, J., & Ruggerone, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08747-8 · Cited by 74
Extracellular ATP as an Inter-Kingdom Signaling Molecule: Release Mechanisms by Bacteria and Its Implication on the Host
Spari, D., & Beldi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155590 · Cited by 78
Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery
Balganesh, M., Kuruppath, S., Marcel, N., Sharma, S., Nair, A. V., & Sharma, U. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00610-10 · Cited by 73
High antimicrobial effectiveness with low hemolytic and cytotoxic activity for PEG/quaternary copolyoxetanes
King, A., Chakrabarty, S., Zhang, W., Zeng, X., Ohman, D. E., Wood, L. F., Abraham, S., Rao, R., & Wynne, K. J. (2014) · Biomacromolecules · doi:10.1021/bm401794p · Cited by 72
Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus
de Carvalho, C. C. C. R., Costa, S. S., Fernandes, P. C. D. B., Couto, I., & Viveiros, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00133 · Cited by 71
Antibiotic Inducibility of the mexXY Multidrug Efflux Operon of Pseudomonas aeruginosa: Involvement of the MexZ Anti-Repressor ArmZ
Hay, T. J. M., Fraud, S., Lau, C. H., Gilmour, C., & Poole, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056858 · Cited by 71
Self-citation
Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
Barbour, A., Schmidt, S., Ma, B., Schiefelbein, L., Rand, K. H., Burkhardt, O., & Derendorf, H. (2009) · Clinical Pharmacokinetics · doi:10.2165/11317100-000000000-00000 · Cited by 71
Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni
Jeon, B., Wang, Y., Hao, H., Barton, Y.-W., & Zhang, Q. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq418 · Cited by 71
Aminoglycosides
Jackson, J., Chen, C., & Buising, K. L. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000012 · Cited by 71
Synergy of clavine alkaloid ‘chanoclavine’ with tetracycline against multi-drug-resistant E. coli
Dwivedi, G. R., Maurya, A., Yadav, D. K., Singh, V., Khan, F., Gupta, M. K., Singh, M., Darokar, M. P., & Srivastava, S. K. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1458654 · Cited by 72
Functional characterization of the NfxB repressor of the mexCD–oprJ multidrug efflux operon of Pseudomonas aeruginosa
Purssell, A., & Poole, K. (2013) · Microbiology · doi:10.1099/mic.0.069286-0 · Cited by 70
Self-citation
Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more
Poole, K. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0666 · Cited by 70
Self-citation
Resistance-nodulation-division efflux pump acrAB is modulated by florfenicol and contributes to drug resistance in the fish pathogenPiscirickettsia salmonis
Sandoval, R., Oliver, C., Valdivia, S., Valenzuela, K., Haro, R. E., Sánchez, P., Olavarría, V. H., Valenzuela, P., Avendaño-Herrera, R. E., Romero, A., et al. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw102 · Cited by 70
Antibióticos betalactámicos
Suárez, C., & Gudiol, F. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2008.12.001 · Cited by 101
Typing and Characterization of Bacteria Using Bottom-up Tandem Mass Spectrometry Proteomics
Boulund, F., Karlsson, R., Gonzales‐Siles, L., Johnning, A., Karami, N., AL-Bayati, O., Åhrén, C., Moore, E. R. B., & Kristiansson, E. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061721 · Cited by 71
Resistance to phenicol compounds following adaptation to quaternary ammonium compounds in Escherichia coli
Soumet, C., Fourreau, E., Grandois, P. L., & Maris, P. (2012) · Veterinary Microbiology · doi:10.1016/j.vetmic.2012.01.030 · Cited by 69
Multiple responses of gram-positive and gram-negative bacteria to mixture of hydrocarbons
Stancu, M. M. (2010) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822010000300016 · Cited by 69
High Prevalence of blaNDM-1, blaVIM, qacE, and qacEΔ1 Genes and Their Association with Decreased Susceptibility to Antibiotics and Common Hospital Biocides in Clinical Isolates of Acinetobacter baumannii
Gomaa, F. A. M., Helal, Z. H., & Khan, M. I. (2017) · Microorganisms · doi:10.3390/microorganisms5020018 · Cited by 69
Folded Synthetic Peptides and Other Molecules Targeting Outer Membrane Protein Complexes in Gram-Negative Bacteria
Robinson, J. A. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00045 · Cited by 69
Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps
German, N., Wei, P., Kaatz, G. W., & Kerns, R. J. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.042 · Cited by 68
Protein Modulator of Multidrug Efflux Gene Expression inPseudomonas aeruginosa
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C. J., Dean, C. R., & Poole, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00543-07 · Cited by 68
Self-citation
The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods
Laudy, A. E., Mrówka, A., Krajewska, J., & Tyski, S. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147131 · Cited by 68
MarR family proteins are important regulators of clinically relevant antibiotic resistance
Beggs, G. A., Brennan, R. G., & Arshad, M. (2019) · Protein Science · doi:10.1002/pro.3769 · Cited by 67
Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes
Cesaro, A., Bettoni, R. R. D., Lascols, C., Mérens, A., Soussy, C., & Cambau, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn077 · Cited by 67
Comparative genomic analysis of Enterococcus faecalis: insights into their environmental adaptations
He, Q., Hou, Q., Wang, Y., Li, J., Li, W., Kwok, L., Sun, Z., Zhang, H., & Zhong, Z. (2018) · BMC Genomics · doi:10.1186/s12864-018-4887-3 · Cited by 67
P-glycoprotein Inhibition for Optimal Drug Delivery
Amin, M. L. (2013) · Drug Target Insights · doi:10.33393/dti.2013.1349 · Cited by 67
The ABC of Biofilm Drug Tolerance: the MerR-Like Regulator BrlR Is an Activator of ABC Transport Systems, with PA1874-77 Contributing to the Tolerance of Pseudomonas aeruginosa Biofilms to Tobramycin
Poudyal, B., & Sauer, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01981-17 · Cited by 65
Biocides as drivers of antibiotic resistance: A critical review of environmental implications and public health risks
Sousa, M., Machado, I., Simões, L. C., & Simões, M. V. (2025) · Environmental Science and Ecotechnology · doi:10.1016/j.ese.2025.100557 · Cited by 72
Molecular mechanisms of AcrB-mediated multidrug export
Zwama, M., & Yamaguchi, A. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.05.005 · Cited by 65
Synthesis and Structure–Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens
Wu, B., Yang, X., & Yan, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00550 · Cited by 65
Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus
Lekshmi, M., Parvathi, A., Adjei, J., Sanford, L. M., Shrestha, U., Kumar, S. H., & Varela, M. F. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.1.1 · Cited by 64
Study of the Multidrug Membrane Transporter of Single Living Pseudomonas aeruginosa Cells Using Size-Dependent Plasmonic Nanoparticle Optical Probes
Nallathamby, P. D., Lee, K. J., Desai, T. J., & Xu, X. N. (2010) · Biochemistry · doi:10.1021/bi100268k · Cited by 64
In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumonia e
Zhou, X.-Y., Ye, X., He, L., Zhang, S.-R., Wang, R., Zhou, J. M., & He, Z.-S. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.15 · Cited by 64
Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries
Yanat, B., Rodríguez-Martínez, J. M., & Touati, A. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2847-x · Cited by 64
Antimicrobial Resistance Profile and ExPEC Virulence Potential in Commensal Escherichia coli of Multiple Sources
Massella, E., Giacometti, F., Bonilauri, P., Reid, C. J., Djordjevic, S. P., Merialdi, G., Bacci, C., Fiorentini, L., Massi, P., Bardasi, L., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10040351 · Cited by 64
Microbial resistance: The role of efflux pump superfamilies and their respective substrates
Garcia, I., Garcia, F. A. D. O., Pereira, P. S., Coutinho, H. D. M., Siyadatpanah, A., Norouzi, R., Wilairatana, P., Pereira, M. D. L., Nissapatorn, V., Tintino, S. R., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120391 · Cited by 67
Determining the resistance of carbapenem-resistantKlebsiella pneumoniaeto common disinfectants and elucidating the underlying resistance mechanisms
Guo, W., Shan, K., Xu, B., & Li, J. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000022 · Cited by 62
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: Exploration of aromatic substituents
Yoshida, K., Nakayama, K., Yokomizo, Y., Ohtsuka, M., Takemura, M., Hoshino, K., Kanda, H., Namba, K., Nitanai, H., Zhang, J. Z., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.037 · Cited by 62
Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003
Chevalier, J., Mulfinger, C., Garnotel, É., Nicolas, P., Davin‐Regli, A., & Pagès, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003203 · Cited by 62
Molecular structure and translocation of a multiple antibiotic resistance region of aPsychrobacter psychrophiluspermafrost strain
Ma, P., Gorlenko, Z., & Mindlin, S. Z. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01635.x · Cited by 64
Wide Variation in Antibiotic Resistance Proteins Identified by Functional Metagenomic Screening of a Soil DNA Library
McGarvey, K. M., Queitsch, K., & Fields, S. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06759-11 · Cited by 63
Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems
Haenni, M., Bour, M., Châtre, P., Madec, J.-Y., Plésiat, P., & Jeannot, K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01847 · Cited by 63
Resistance mechanisms
Çağ, Y., Çaşkurlu, H., Fan, Y., Cao, B., & Vahaboğlu, H. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.09.14 · Cited by 62
Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter
Kadlec, K., Kehrenberg, C., & Schwarz, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl498 · Cited by 61
The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa
Terzi, H. A., Külah, C., & Çiftçi, İ. H. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-014-1692-2 · Cited by 61
MmpS5/MmpL5 as an efflux pump in Mycobacterium species
Briffotaux, J., Huang, W., Wang, X., & Gicquel, B. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.08.001 · Cited by 59
Overexpression of the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is Driven by Inactivation of Its Local Repressor FepR
Guérin, F., Galimand, M., Tuambilangana, F., Courvalin, P. M., & Cattoir, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106340 · Cited by 60
Enhancing isoprenoid production through systematically assembling and modulating efflux pumps in Escherichia coli
Wang, J., Xiong, Z., Li, S., & Wang, Y. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5062-z · Cited by 60
Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA)
Mohtar, M., Johari, S. A., Li, A. R., Mazurah, M. I., Mustafa, S., Ali, A. M., & Basri, D. F. (2009) · Current Microbiology · doi:10.1007/s00284-009-9416-9 · Cited by 60
Antimicrobial photodynamic activity of porphyrin derivatives: potential application on medical and water disinfection
Carvalho, C. M. B., Tomé, J. P. C., Faustino, M. A. F., Neves, M. G. P. M. S., Tomé, A. C., Cavaleiro, J. A. S., Costa, L., Alves, E., Oliveira, A. S., Cunha, Â., et al. (2009) · Journal of Porphyrins and Phthalocyanines · doi:10.1142/s1088424609000528 · Cited by 60
Tigecycline: in-vitro performance as a predictor of clinical efficacy
Hawkey, P. M., & Finch, R. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01621.x · Cited by 60
Genomewide Overexpression Screen for Fosfomycin Resistance in Escherichia coli: MurA Confers Clinical Resistance at Low Fitness Cost
Couce, A., Briales, A., Rodríguez-Rojas, A., Costas, C., Pascual, Á., & Blázquez, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06122-11 · Cited by 59
Possible Role of Curcumin as ection an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa
Negi, N. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/8329.4965 · Cited by 59
Phototherapy-based multifunctional nanoplatform for synergistic therapy against drug resistance bacteria: Progress, advances and challenges
Yu, B., Liu, Q., Sun, J., Fu, X., Zhang, Y., & Sun, X. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.150705 · Cited by 59
Anaerobic expression of the gadE-mdtEF multidrug efflux operon is primarily regulated by the two-component system ArcBA through antagonizing the H-NS mediated repression
Deng, Z., Shan, Y., Pan, Q., Gao, X., & Yan, A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00194 · Cited by 58
Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island
Chakraborti, S., Mandal, A. K., Sarwar, S., Singh, P., Chakraborty, R., & Chakrabarti, P. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.044 · Cited by 59
MexT Functions as a Redox-Responsive Regulator Modulating Disulfide Stress Resistance in Pseudomonas aeruginosa
Fargier, E., Aogáin, M. M., Mooij, M. J., Woods, D. F., Morrissey, J. P., Dobson, A. D. W., Adams, C., & O’Gara, F. (2012) · Journal of Bacteriology · doi:10.1128/jb.06632-11 · Cited by 58
Contribution of SecDF to Staphylococcus aureusresistance and expression of virulence factors
Quiblier, C., Zinkernagel, A. S., Schuepbach, R. A., Berger‐Bächi, B., & Senn, M. M. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-72 · Cited by 58
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship
Corcione, S., Lupia, T., Maraolo, A. E., Pinna, S. M., Gentile, I., & Rosa, F. G. D. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000598 · Cited by 59
Seasonality Determines the Variations of Biofilm Microbiome and Antibiotic Resistome in a Pilot-Scale Chlorinated Drinking Water Distribution System Deciphered by Metagenome Assembly
Ke, Y., Sun, W., Chen, X., Zhu, Y., Guo, X., Yan, W., & Xie, S. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c01980 · Cited by 57

Authors: Poole, K.
Affiliations: Queen's University (CA)
Corresponding author: Poole, Keith
ORCID: Poole, Keith
Venue: Journal of Antimicrobial Chemotherapy
Publisher: Oxford University Press (OUP)
Published: 2005-05-24
Volume: 56
Issue: 1
Pages: 20-51
ISSN: 0305-7453 (ISSN-L)
1460-2091
DOI: 10.1093/jac/dki171
OpenAlex: W2131256712
Cited by: 1,082
References: 733
Citations by year: 2026: 37 · 2025: 50 · 2024: 54 · 2023: 54 · 2022: 43 · 2021: 63 · 2020: 57 · 2019: 52 · 2018: 48 · 2017: 52 · 2016: 70 · 2015: 52 · 2014: 61 · 2013: 57 · 2012: 54
FWCI: 2.24
Type: journal article
Language: en
Open access: closed
Locations: Journal of Antimicrobial Chemotherapy (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords: efflux-mediated resistance, antimicrobial resistance, multidrug efflux pumps, biocide resistance, multidrug resistance, plasmid-encoded resistance genes, integrons, transposable elements, mobile genetic elements, efflux pump inhibitors, Gram-negative bacteria, intrinsic resistance, acquired resistance
MeSH terms: Aminoglycosides, Anti-Bacterial Agents, Biological Transport, Chloramphenicol, Tetracycline, Fluoroquinolones, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Efflux-mediated antimicrobial resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks